Recent Headlines
Within Biotechnology
International Stem Cell Corporation Planning European Subsidiary
International Stem Cell Corporation (OTCBB:ISCO) announced that it had entered into a Memorandum of Understanding with ARG Vermogensverwaltung AG ('ARG'), a German Investment Fund, to create a new European subsidiary ('ISCO Europe') to be funded with up to $10 million of capital derived from ARG... - July 28, 2010 - International Stem Cell Corporation
ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.
ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. Sclerostin inhibits osteoblast activity via antagonism of the wnt signaling pathway and plays a key role in the regulation of bone formation. Reports show that sclerostin expression and/or... - July 27, 2010 - ALPCO
Bioo Scientific Releases the ExoMir™ Kit to Facilitate RNA Analysis in Cell-Free Fluids
Bioo Scientific’s new ExoMir™ kit simplifies the fractionation of and RNA extraction from exosomes and other microparticles in cell-free fluids. - July 26, 2010 - Bioo Scientific
Stevens Hosts 2010 Metro Area NEMS/MEMS Workshop
Nanomanufacturing Workshop hosted by Stevens Institute of Technology on Monday, July 26th in Hoboken, New Jersey. - July 24, 2010 - Stevens Institute of Technology
Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform
CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions
AnaSpec’s Published References Pass 1000
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 1000. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - July 21, 2010 - AnaSpec, EGT Group
ALN Publishes Article on Whole Animal Database by Noesys Data
Article on Artios Software Suite is published by ALN, a respected industry publication covering animal research institutions and markets. - July 21, 2010 - Noesys Data
NSF Funds Infection-Resistant Orthopedic Research
Researchers at Stevens explore inkjet printing of drug-eluting, bioresorbable micropatterns onto the surface of orthopedic implants to prevent bacterial infection of the implants. - July 21, 2010 - Stevens Institute of Technology
Wockhardt Foundation Achieves Another Milestone - Over 200 Cleft Surgeries in Association with Smile Train
Wockhardt Foundation, in collaboration with Smile train has successfully completed over 200 surgeries. - July 18, 2010 - Wockhardt Foundation
200,000 Patients Screened by Wockhardt Foundation Within 200 Days
Wockhardt Foundation screens over 200,000 patients. - July 18, 2010 - Wockhardt Foundation
InnoCore and Nanomi Strengthen Collaboration in Microsphere Technology for Peptide and Protein Delivery
InnoCore Technologies BV and Nanomi BV announce a strategic collaboration for the development of advanced monodisperse biodegradable microsphere-based controlled release formulations for the sustained delivery of biotherapeutics. - July 14, 2010 - Nanomi
NanoLetters Publishes Dr. Yong Shi’s Energy Harvesting Technology
Dr. Shi’s research focuses on miniature energy harvesting technologies that could potentially power wireless electronics, portable devices, stretchable electronics, and implantable biosensors. - July 11, 2010 - Stevens Institute of Technology
International Stem Cell Corp. and India's Largest Eye Hospital to Develop Stem Cell-Based Treatment for Corneal Vision Impairment
International Stem Cell Corporation and Sankara Nethralaya Eye Hospital, a nonprofit medical facility, are collaborating to develop ISCO's 'CytoCor™' stem cell-derived corneal tissue. The goal is to use CytoCor, human tissue derived from pluripotent human stem cells, to treat corneal blindness and vision impairment. - July 11, 2010 - International Stem Cell Corporation
The NIH Awards Aciont® a Small Business Catalyst Award Grant Accelerating Innovative Research
Aciont is awarded a phase I SBIR $214K grant for the project titled “Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®.” - July 08, 2010 - Aciont Inc.
Consumers Report Positive Results in Reducing Symptoms of Lactose Intolerance with Lactagen
Customer Experience Reports indicate relief from the symptoms of lactose intolerance using the Lactagen® program of colonic adaptation. - July 02, 2010 - Lactagen
Red Cedar Technology Elects New Board Chairman
Robert Ryan Joins Red Cedar Technology's Leadership Team. - July 02, 2010 - Red Cedar Technology
Red Cedar Technology Expands Business Development Team
Angelo Flemings joins Red Cedar Technology as Director of Business Development. - July 02, 2010 - Red Cedar Technology
Stemedica Announces the Appointment of Dr. Cesar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the United States. - July 02, 2010 - Stemedica Cell Techechnologies
Wockhardt Foundation Awarded ‘Pharma CSR Organization of the Year 2010’
Wockhardt Foundation wins the CSR award under the leadership of Huzaifa Khorakiwala who through his Human Values has created a team of dedicated warriors to work towards the upliftment of the poor weak and needy. - July 02, 2010 - Wockhardt Foundation
Colorado BioScience Association Commends Boettcher Foundation on Historic Launch of Webb-Waring Biomedical Research Program & Inaugural Class of 'Boettcher Investigators'
Colorado BioScience Association commends Boettcher Foundation on launching the new Webb-Waring Biomedical Research Program and its 2010 (Inaugural) Class of Boettcher Investigators. This new grant program will ensure that the Webb-Waring legacy lives on both through the discovery of new knowledge that improves human health and through the investment in and advancement of early-career scientists. - July 01, 2010 - Colorado BioScience Association
The 5th BIO KOREA 2010, Korea’s Largest Exhibition & Conference, on Biotech in Seoul, 1-3 September
The 5th BIO KOREA 2010 Conference & Exhibition will be held from September 1 to 3, 2010 at COEX in Seoul/Korea. BIO KOREA of this year offers a variety of high-level conference, international exhibition and partnership events and provides an opportunity to find business and technology partners. It expects to 265 companies and about 19,000 visitors from across the globe. - June 29, 2010 - Bio Korea
Functional Genetics Announces Two Separate Awards from the National Institute of Allergy and Infectious Diseases to Develop Broad Spectrum Antivirals
Functional Genetics, Inc. today announced the awarding of two different Phase II SBIR awards from the National Institute of Allergy and Infectious Diseases (NIAID) to pursue innovative approaches for antibody-based targeting of infectious diseases. Under the terms of the agreement, Functional... - June 29, 2010 - Functional Genetics, Inc.
Dr. Mitola and Cognitive Radio Are Featured on Computing Now
Dr. Joseph Mitola III, Vice President for the Research Enterprise at Stevens Institute of Technology, is the subject of a recent article on Computing Now which details the benefits and development of Cognitive Radio (CR), the intelligent wireless technology coined by Dr. Mitola in... - June 25, 2010 - Stevens Institute of Technology
ONR Continues Major Funding of ACCeSS Research Center at Stevens
The Atlantic Center for the Innovative Design and Control of Small Ships (ACCeSS) at Stevens Institute of Technology announced major funding for the next five years worth $4.5 million by the Office of Naval Research (ONR) as part of its National Naval Responsibility – Naval Engineering... - June 24, 2010 - Stevens Institute of Technology
Economic Development Executive Holli Baumunk Named President & CEO of the Colorado BioScience Association Effective July 12
Holli Baumunk, Vice President of the Metro Denver Economic Development Corporation for the past seven years, has been named President & CEO of the Colorado BioScience Association (CBSA) July 12. The announcement is made by Rick Jory, CBSA Board Chairperson, who says Baumunk was unanimously... - June 24, 2010 - Colorado BioScience Association
NSF Funds Mathematical Research at Stevens
Dr. Alexei Miasnikov, Dr. Robert Gilman and Alexander Ushakov of Stevens Institute of Technology were recently awarded NSF funding that enables them to organize the thematic semester on geometric, combinational and computational group theory at the Centre de Recherches Mathmatiques (CRM) in Montreal. - June 23, 2010 - Stevens Institute of Technology
AnaSpec Introduces New SensoLyte® uPA & tPA Assay Kits
AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. - June 19, 2010 - AnaSpec, EGT Group
Dr. Mitola Delivered Keynote at CrownCom 2010
On June 9th - 11th 2010, in Cannes, France, Dr. Joseph Mitola III, Vice President for the Research Enterprise at Stevens Institute of Technology, delivered a keynote address at the CrownCom 2010 International Conference on Cognitive Radio Oriented Wireless Networks and Communication. - June 19, 2010 - Stevens Institute of Technology
Advanced Cell Technology Awarded Broad Patent for Production of Retinal Pigment Epithelial Cells
This broad patent gives Advanced Cell Technology the opportunity to have a monopoly around embryonic stem cells derived from RPE cells. There are over 200 diseases and conditions which potentially be treated with RPE-derived cells. - June 18, 2010 - Advanced Cell Technology, Inc.
AnaSpec Signs Distribution Agreement with Bioeasy Diagnostica
AnaSpec, Inc. and Bioeasy Diagnostica today announced a non-exclusive distributor agreement that will allow Bioeasy Diagnostica to distribute AnaSpec’s catalog and custom products throughout Brasil. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec... - June 18, 2010 - AnaSpec, EGT Group
BIOCIUS Life Sciences and BlueSky Biotech Extend Partnership, Provide Validated Enzymes Fully‐Validated SIRT1 Enhances Drug Discovery Investigation
BIOCIUS Life Sciences Inc., developers of the RapidFire® highthroughputmass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry’s only Sirtuin (SIRT, silent mating type information regulation... - June 18, 2010 - Blue Sky Biotech
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010 - ALPCO
Wockhardt Foundation Celebrates Service Commitment Day on 5th & 7th June with Zest, Energy & Activities
Dedicated warriors of Wockhardt Foundation across all sites, celebrated Service Commitment Day on 5th & 7th of June, in a unique fashion. US operations in both Morton Grove Pharmaceuticals and Wockhardt USA New Jersey conducted a food drive for local food banks that serve the poor, weak &... - June 13, 2010 - Wockhardt Foundation
AsymmetRx Medical Signs Multi Year Agreement with Ventana Medical a Member of the Roche Group
AsymmetRx Medical, Inc. an Acton, MA based Biotechnology Company, announced the signing of a license agreement with Ventana Medical, A member of the Roche Group. This agreement provides Ventana with the exclusive license and distribution rights of their patented Prostate Cancer Diagnostic tool... - June 11, 2010 - AsymmetRx Medical, Inc.
ALL-TAIL™ Kit for Poly(A) Tail Analysis Launched
Bioo Scientific launched the ALL-TAIL™ Kit for size and sequence analysis of the poly(A) tail and 3’ UTR sequence of mRNA. - June 10, 2010 - Bioo Scientific
International Stem Cell Corporation's Parthenogenetic Stem Cell Patent Approved by the United States Patent and Trademark Office
International Stem Cell Corporation announced that the United States Patent and Trademark Office has granted ISCO a patent relating to the company’s development of human non-embryonic parthenogenetic stem cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, that could create a universal cell benefiting most the of the world's population, and that avoids ethical issues. - June 10, 2010 - International Stem Cell Corporation
Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies in June 14 DIA Session
Dr. Michael Rosenberg will describe how fast access to metrics, flexible processes, and automated technology enable study monitors to increase efficiency - June 10, 2010 - Health Decisions
ALPCO Diagnostics Prepares for Launch of Unique Immunoassays
ALPCO Diagnostics announces the recent hiring of Leon F. Hebert Jr., Ph.D. As ALPCO’s new Diabetes and Obesity Product Manager, Dr. Hebert will be charged with overseeing the launch of several new ELISA research tools, including: Mouse Proinsulin ELISA, Rat Proinsulin ELISA, Mouse C-peptide... - June 09, 2010 - ALPCO
Kenneth J. Altorfer Academic Complex Groundbreaking Ceremony
A groundbreaking ceremony for the construction of the Kenneth J. Altorfer Academic Complex was held on June 2nd, 2010, in honor of Stevens Institute of Technology class of 1950 alumnus Kenneth J. Altorfer. The Stevens community joined Mr. Altorfer's surviving family members, including his wife Mrs. - June 05, 2010 - Stevens Institute of Technology
The Allogeneic Adult Stem Cells Company Announcing Appointment of Dr. Lev Verkh
Lev Verkh is now a part of Stemedica, the allogeneic adult stem cells manufacturing company for effective stem cell clinical trials, thus improving the life of humans. - June 05, 2010 - Stemedica Cell Techechnologies
AnaSpec Introduces Rhodamine 110 Labeled GO® Peptides
Rhodamine 110 (Rh110)-labeled peptides are used in the study of a number of protease activity. - June 05, 2010 - AnaSpec, EGT Group
Health Decisions Encourages DIA Attendees to Demand More Than the Industry’s 10% Rate of On-Time Enrollment in Clinical Trials (Booth 929)
CRO demonstrates techniques that reverse the tide of enrollment delays in clinical research. - May 29, 2010 - Health Decisions
Governor Bill Ritter Jr. Signs Executive Orders Initiated by Colorado BioScience Association (CBSA) to Ensure Continued Investment in Life Sciences
Governor Bill Ritter Jr. signed two executive orders initiated by the Colorado BioScience Association (CBSA) today, calling for an online “Investment Opportunity Index” to classify opportunities for capital investment within the bioscience and cleantech industries, as well as a quarterly Roundtable on Venture Capital with the Governor – focusing on bioscience, renewable energy and aerospace. - May 28, 2010 - Colorado BioScience Association
AnaSpec Introduces New SensoLyte® GSH and GST Assay Kits
AnaSpec has introduced two new Glutathione (GSH) related kits - the SensoLyte® Glutathione Cellular Assay Kit and the SensoLyte® GST Activity Assay Kit to complement the colorimetric and fluorimetric SensoLyte® Total GSH assay kits. The SensoLyte® Glutathione Cellular Assay Kit... - May 28, 2010 - AnaSpec, EGT Group
1,50,000 Patients in the First 5 Months: Another Milestone by Wockhardt Foundation
Wockhardt Foundation completed 1,50,000 medical check ups through its 2 Mobile Medical Unit programmes in the first 5 months of 2010. - May 28, 2010 - Wockhardt Foundation
Stevens Hosts the 8th International Conference on Business Process Management
The internationally acclaimed BPM conference appears in the U.S. for the first time September 13-16, 2010. Stevens Institute of Technology welcomes leaders from both industry and academia to discuss Business Process Management innovations. - May 27, 2010 - Stevens Institute of Technology
AnaSpec Introduces Anti-5-Methylcytidine Monoclonal Antibody
AnaSpec has introduced the popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. - May 23, 2010 - AnaSpec, EGT Group
Ritter Pharmaceuticals Launches Redesigned Website for Lactagen
Ritter Pharmaceuticals, Inc. announces the launch of a newly redesigned website for their lactose intolerance product, Lactagen (www.lactagen.com). - May 23, 2010 - Lactagen
Nature Magazine Features Dr. Choi’s Nano-Engineering Research
As a recipient of the prestigious 2010 Young Investigator Program (YIP) Award by the Office of Naval Research (ONR), Dr. Choi's work in Nano-Engineering is dramatically enhancing the corrosion resistance capabilities of Naval Vessels while also highlighting his unique career path and demonstrating the innovative research of faculty within Stevens. - May 22, 2010 - Stevens Institute of Technology
International Stem Cell Corporation Enters Into Strategic Alliance to Automate Cornea Tissue Production
International Stem Cell Corporation (OTCBB:ISCO), www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership (TAP), www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue. The alliance... - May 22, 2010 - International Stem Cell Corporation